108 related articles for article (PubMed ID: 10653004)
1. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.
Fujisawa H; Reis RM; Nakamura M; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 2000 Jan; 80(1):65-72. PubMed ID: 10653004
[TBL] [Abstract][Full Text] [Related]
2. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.
Rickert CH; Riemenschneider MJ; Schachenmayr W; Richter HP; Bockhorn J; Reifenberger G; Paulus W
Brain Pathol; 2009 Jul; 19(3):431-8. PubMed ID: 18691268
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel genetic alterations in samples of malignant glioma patients.
Milinkovic V; Bankovic J; Rakic M; Stankovic T; Skender-Gazibara M; Ruzdijic S; Tanic N
PLoS One; 2013; 8(12):e82108. PubMed ID: 24358143
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity preferentially occurs in early replicating regions in cancer genomes.
Pedersen BS; De S
Nucleic Acids Res; 2013 Sep; 41(16):7615-24. PubMed ID: 23793816
[TBL] [Abstract][Full Text] [Related]
6. Whole gain of chromosome 19, not co-gain of chromosomes 19 and 20, characterizes a class of glioblastomas with more favorable outcomes.
Nuechterlein N; Shelbourn A; Cimino PJ
J Neuropathol Exp Neurol; 2023 Dec; 83(1):53-57. PubMed ID: 37964704
[No Abstract] [Full Text] [Related]
7. The Role of Genetic Analysis in Distinguishing Multifocal and Multicentric Glioblastomas: An Illustrative Case.
Karatsu K; Tamura R; Yo M; Nogawa H; Hino U; Kitamura Y; Ueda R; Toda M
Case Rep Oncol; 2024; 17(1):113-121. PubMed ID: 38260034
[TBL] [Abstract][Full Text] [Related]
8. Genetics of Glioblastoma in Moroccan population: Review of literature.
Idrissi HHE; Boujmia OKA; Nadifi S; Dehbi H
IBRO Rep; 2018 Dec; 5():133-136. PubMed ID: 30569026
[TBL] [Abstract][Full Text] [Related]
9. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge.
Sturm D; Bender S; Jones DT; Lichter P; Grill J; Becher O; Hawkins C; Majewski J; Jones C; Costello JF; Iavarone A; Aldape K; Brennan CW; Jabado N; Pfister SM
Nat Rev Cancer; 2014 Feb; 14(2):92-107. PubMed ID: 24457416
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome 10q in glioblastomas, and its association with other genetic alterations and survival in Indian patients.
Kakkar A; Suri V; Jha P; Srivastava A; Sharma V; Pathak P; Sharma MC; Sharma MS; Kale SS; Chosdol K; Phalak M; Sarkar C
Neurol India; 2011; 59(2):254-61. PubMed ID: 21483128
[TBL] [Abstract][Full Text] [Related]
11. The definition of primary and secondary glioblastoma.
Ohgaki H; Kleihues P
Clin Cancer Res; 2013 Feb; 19(4):764-72. PubMed ID: 23209033
[TBL] [Abstract][Full Text] [Related]
12. Genetic pathways to primary and secondary glioblastoma.
Ohgaki H; Kleihues P
Am J Pathol; 2007 May; 170(5):1445-53. PubMed ID: 17456751
[TBL] [Abstract][Full Text] [Related]
13. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
[TBL] [Abstract][Full Text] [Related]
14. Mutations of PTEN gene in gliomas correlate to tumor differentiation and short-term survival rate.
Yang Y; Shao N; Luo G; Li L; Zheng L; Nilsson-Ehle P; Xu N
Anticancer Res; 2010 Mar; 30(3):981-5. PubMed ID: 20393024
[TBL] [Abstract][Full Text] [Related]
15. PTEN signaling pathways in glioblastoma.
Koul D
Cancer Biol Ther; 2008 Sep; 7(9):1321-5. PubMed ID: 18836294
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
[TBL] [Abstract][Full Text] [Related]
17. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
18. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
[TBL] [Abstract][Full Text] [Related]
19. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
[TBL] [Abstract][Full Text] [Related]
20. Intramedullary Spinal Cord Tumors: Whole-Genome Sequencing to Assist Management and Prognosis.
Mayol Del Valle M; Morales B; Philbrick B; Adeagbo S; Goyal S; Newman S; Frontera NL; Nduom E; Olson J; Neill S; Hoang K
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
